Results show the potential of a real-time, non-invasive blood test to quantify tumor drug target expression and to stratify therapeutic…
November 15, 2024 17:52 ET | Source: Protara Therapeutics NEW YORK, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq:…
Data presented in an oral session at the Society for Immunotherapy of Cancer 39th Annual Meeting, where it was selected…
November 09, 2024 13:00 ET | Source: Replimune Group Inc Oral presentation highlighting IGNYTE primary analysis data shows anti-tumor activity…
New data showed a correlation between the levels of neural cell adhesion molecule (NCAM or CD56) expression and response and…
November 08, 2024 10:00 ET | Source: Medicenna Therapeutics Corp. MDNA113 is a novel IL-13Rα2 tumor-targeted and “masked” BiSKIT…
November 08, 2024 09:10 ET | Source: SEALSQ Geneva, Switzerland, Nov. 08, 2024 (GLOBE NEWSWIRE) -- SEALSQ Corp (NASDAQ: LAES)…
CloudFirst Continues Strong Financial Performance Along with Expansion into the United Kingdom and Operational Success Following Flagship Solutions Group Integration…
Robust and sustainable infrastructure essential to maximize AI investments SINGAPORE, Nov. 4, 2024 /PRNewswire/ -- Digital Realty (NYSE: DLR), the largest…
Robust and sustainable infrastructure essential to maximize AI investments SINGAPORE, Nov. 4, 2024 /PRNewswire/ -- Digital Realty (NYSE: DLR), the largest…